Goldman Sachs Group Analysts Give Reckitt Benckiser Group (LON:RB) a GBX 7,200 Price Target

Share on StockTwits

Goldman Sachs Group set a GBX 7,200 ($94.08) price target on Reckitt Benckiser Group (LON:RB) in a report issued on Thursday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other analysts have also recently weighed in on RB. JPMorgan Chase & Co. set a €33.40 ($38.84) price target on Siemens Healthineers and gave the stock a neutral rating in a report on Thursday. Bryan, Garnier & Co reduced their price target on GlaxoSmithKline from GBX 1,710 ($22.34) to GBX 1,660 ($21.69) and set a neutral rating on the stock in a report on Thursday, May 2nd. Royal Bank of Canada cut 3M from an outperform rating to a sector perform rating and reduced their target price for the company from $207.00 to $176.00 in a report on Monday, July 8th. UBS Group cut Telstra from a buy rating to a neutral rating in a report on Monday, July 1st. Finally, Morgan Stanley reiterated an overweight rating on shares of in a report on Thursday, June 20th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the company. The stock has a consensus rating of Hold and an average price target of GBX 7,211.11 ($94.23).

LON:RB opened at GBX 6,595 ($86.18) on Thursday. The company has a market capitalization of $46.76 billion and a PE ratio of 21.64. The company has a debt-to-equity ratio of 80.49, a quick ratio of 0.47 and a current ratio of 0.65. The business’s 50-day moving average price is GBX 6,384.22. Reckitt Benckiser Group has a 1-year low of GBX 5,559 ($72.64) and a 1-year high of GBX 7,174 ($93.74).

In other Reckitt Benckiser Group news, insider Andrew R. J. Bonfield purchased 146 shares of the company’s stock in a transaction on Tuesday, May 21st. The shares were purchased at an average cost of GBX 6,290 ($82.19) per share, with a total value of £9,183.40 ($11,999.74). Also, insider Adrian Nevil Hennah sold 13,701 shares of the business’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of GBX 6,143 ($80.27), for a total value of £841,652.43 ($1,099,767.97).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: Price to Earnings Ratio (PE) Basics

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Slack  Earns Neutral Rating from Analysts at Credit Suisse Group
Slack Earns Neutral Rating from Analysts at Credit Suisse Group
Slack  Coverage Initiated by Analysts at Morgan Stanley
Slack Coverage Initiated by Analysts at Morgan Stanley
Solaris Oilfield Infrastructure  Coverage Initiated by Analysts at Citigroup
Solaris Oilfield Infrastructure Coverage Initiated by Analysts at Citigroup
Tanger Factory Outlet Centers  Upgraded to “Hold” at Zacks Investment Research
Tanger Factory Outlet Centers Upgraded to “Hold” at Zacks Investment Research
Sterling Bancorp  Coverage Initiated at B. Riley
Sterling Bancorp Coverage Initiated at B. Riley
Restoration Hardware  Upgraded by ValuEngine to “Hold”
Restoration Hardware Upgraded by ValuEngine to “Hold”


© 2006-2019 Ticker Report